Corebridge Financial enters the week after its Q1 earnings print in a rare split: the stock added 5.7% and analysts turned more constructive, yet short sellers have been building positions at the fastest pace in months.
The short-interest picture is the week's most telling story. The SI % of Free Float has climbed to 6.7% — up 13% in a single week and an extraordinary 64% over the past month. To put that in context, at the start of April, estimated short interest was running around 21.5 million shares; it is now approaching 34.9 million. That kind of pace, sustained over five weeks, is not noise. Borrow availability, however, remains accessible — cost to borrow is a low 0.45% and has eased roughly 12% over the past month. The lending pool is not under stress, which means new shorts are finding it easy to add. Availability is at its tightest of the year on a utilization basis, but borrow cost compression tells the opposite story: there is still ample supply in the pool to satisfy demand at very cheap rates.
Options, by contrast, offer no corroboration of the bearish build. The put/call ratio at 0.30 is fractionally below its 20-day average of 0.32 and near the 52-week low of 0.30 — options traders are not reaching for downside protection, they are broadly neutral-to-bullish on the print. The ORTEX short score climbed sharply to 63.4 on May 5, up from around 55 in late April, reflecting the acceleration in short positioning. That gap between a rising short score and flat options sentiment is the tension worth watching.
The Street's immediate reaction to Q1 was positive. Keefe, Bruyette & Woods raised its target to $38 from $31 on May 6, the day after the announcement, while maintaining its Outperform. That move is significant: KBW had cut the same target from $32 to $31 in early April during the broader tariff sell-off. A $7 one-day lift, back above the pre-correction level, signals the quarter was well-received. Most of the other active coverage remains constructively positioned — B of A holds a Buy with a $40 target, Wells Fargo and Barclays both carry Overweight ratings, and Mizuho's Outperform has a $31 target after the mid-April trim. UBS is the outlier with a Neutral at $29 — roughly in line with the current price of $28.46 and the only firm flagging real downside. The consensus mean target at $34.77 implies roughly 22% upside, and the forward P/E of 5.2x against consensus EPS of around $4.88 underlines how cheaply the market is pricing the retirement-products franchise relative to its earnings capacity.
Ownership tells the longer structural story. Nippon Life holds 25.3% of shares, and AIG has been a steady seller — reducing its position by around 24.7 million shares in the most recent filing window, now down to 5.3%. Pzena and Vanguard each added over 3 million shares in Q1 2026, and State Street added 3.5 million in the most recent period. The bull case hinges on durable Individual Retirement segment flows, the benefit of realized bond gains from falling rates, and 2027 EPS estimates that reportedly run 5% above Street consensus. The bear case centres on equity-market weakness dragging fee income and the hedging costs that rise with volatility — tensions that the April drawdown illustrated in real time before the recovery. Peers EQH gained 5.3% on the week and JXN fell 6.1%, underscoring how differently the market is treating names in the same retirement-income space.
The key question heading into summer is whether the short buildup — which accelerated well before, and continued through, the earnings release — reflects a structural thesis on rate sensitivity and hedging costs, or a tactical position that faces a squeeze with the next catalyst now three months away on August 3. With borrow this cheap, the cost of staying short is negligible, but the stock has just put in its best month in a while and the highest-conviction bulls are raising targets.
See the live data behind this article on ORTEX.
Open CRBG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
